Department of Bioethics & Humanities, Seattle, Washington, USA.
Department of Medical Science, Former Dean of Medicine and Biological Sciences, Brown University, Providence, Rhode Island, USA.
Andrology. 2024 Oct;12(7):1605-1609. doi: 10.1111/andr.13649. Epub 2024 Apr 19.
Efforts to develop reversible male contraceptives analogous to female oral contraceptives are underway and may be introduced in the next decade. The advent of novel male contraceptives provides an opportunity for an ethical reformulation of the contraceptive paradigm given the relational, rather than individual, nature of sexual relationships, and family planning. For individuals in any sexual relationship that could result in pregnancy, issues of reproductive autonomy, freedom, equality in reproductive decision-making and risks-both of side effects and of unintended pregnancies-are significant. Historically, however, women have been attributed the greatest responsibilities simultaneously with the most restrictions on their freedom of choice and access to reproductive care.
In this paper, we extend our prior "shared risk" model of male contraception to one of "shared risk and responsibility" to ethically inform this discourse.
This updated framework more fully captures the complexity of this novel technology and may be of use to regulatory and legal agencies grappling with an intervention that poses medical risks to the member of the relationship who does not face risks of becoming pregnant.
目前正在努力开发类似于女性口服避孕药的可逆男性避孕药,并且可能在未来十年内推出。新型男性避孕药的出现为重新制定避孕模式提供了一个机会,因为性关系具有关系性而非个体性,而计划生育也是如此。对于任何可能导致怀孕的性关系中的个人来说,生殖自主权、自由、生殖决策中的平等以及副作用和意外怀孕的风险等问题都非常重要。然而,从历史上看,女性同时承担着最大的责任,同时对她们的选择自由和获得生殖护理的机会限制最多。
在本文中,我们将先前的“男性避孕共同风险”模型扩展到“共同风险和责任”模型,以从伦理角度为这一讨论提供信息。
这个更新的框架更充分地捕捉到了这项新技术的复杂性,可能对正在努力应对这种对关系中不面临怀孕风险的一方成员带来医疗风险的干预措施的监管和法律机构有用。